Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EC-5026 by Eicosis for Diabetic Neuropathic Pain: Likelihood of Approval
EC-5026 is under clinical development by Eicosis and currently in Phase I for Diabetic Neuropathic Pain. According to GlobalData, Phase...
Data Insights
EC-5026 by Eicosis for Inflammatory Pain: Likelihood of Approval
EC-5026 is under clinical development by Eicosis and currently in Phase I for Inflammatory Pain. According to GlobalData, Phase I...